These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 14711889)

  • 1. Development and testing of new screening method for keratan sulfate in mucopolysaccharidosis IVA.
    Tomatsu S; Okamura K; Taketani T; Orii KO; Nishioka T; Gutierrez MA; Velez-Castrillon S; Fachel AA; Grubb JH; Cooper A; Thornley M; Wraith E; Barrera LA; Giugliani R; Schwartz IV; Frenking GS; Beck M; Kircher SG; Paschke E; Yamaguchi S; Ullrich K; Isogai K; Suzuki Y; Orii T; Kondo N; Creer M; Noguchi A
    Pediatr Res; 2004 Apr; 55(4):592-7. PubMed ID: 14711889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucopolysaccharidosis IVA: correlation between genotype, phenotype and keratan sulfate levels.
    Dũng VC; Tomatsu S; Montaño AM; Gottesman G; Bober MB; Mackenzie W; Maeda M; Mitchell GA; Suzuki Y; Orii T
    Mol Genet Metab; 2013; 110(1-2):129-38. PubMed ID: 23876334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of keratan sulfate level in mucopolysaccharidosis type IVA by liquid chromatography-tandem mass spectrometry.
    Tomatsu S; Montaño AM; Oguma T; Dung VC; Oikawa H; de Carvalho TG; Gutiérrez ML; Yamaguchi S; Suzuki Y; Fukushi M; Kida K; Kubota M; Barrera L; Orii T
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S35-42. PubMed ID: 20107903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis.
    Khan SA; Mason RW; Giugliani R; Orii K; Fukao T; Suzuki Y; Yamaguchi S; Kobayashi H; Orii T; Tomatsu S
    Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of an LC-MS/MS assay for detecting relevant disaccharides from keratan sulfate as a biomarker for Morquio A syndrome.
    Martell LA; Cunico RL; Ohh J; Fulkerson W; Furneaux R; Foehr ED
    Bioanalysis; 2011 Aug; 3(16):1855-66. PubMed ID: 21877895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mucopolysaccharidosis IVA (Morquio A syndrome): clinical, biological and therapeutic aspects].
    Bouzidi H; Khedhiri S; Laradi S; Ferchichi S; Daudon M; Miled A
    Ann Biol Clin (Paris); 2007; 65(1):5-11. PubMed ID: 17264033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetics and metabolism, special edition: Diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA.
    Peracha H; Sawamoto K; Averill L; Kecskemethy H; Theroux M; Thacker M; Nagao K; Pizarro C; Mackenzie W; Kobayashi H; Yamaguchi S; Suzuki Y; Orii K; Orii T; Fukao T; Tomatsu S
    Mol Genet Metab; 2018 Sep; 125(1-2):18-37. PubMed ID: 29779902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical and reliable enzyme test for the detection of mucopolysaccharidosis IVA (Morquio Syndrome type A) in dried blood samples.
    Camelier MV; Burin MG; De Mari J; Vieira TA; Marasca G; Giugliani R
    Clin Chim Acta; 2011 Sep; 412(19-20):1805-8. PubMed ID: 21684269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keratan sulphate levels in mucopolysaccharidoses and mucolipidoses.
    Tomatsu S; Okamura K; Maeda H; Taketani T; Castrillon SV; Gutierrez MA; Nishioka T; Fachel AA; Orii KO; Grubb JH; Cooper A; Thornley M; Wraith E; Barrera LA; Laybauer LS; Giugliani R; Schwartz IV; Frenking GS; Beck M; Kircher SG; Paschke E; Yamaguchi S; Ullrich K; Haskins M; Isogai K; Suzuki Y; Orii T; Kondo N; Creer M; Okuyama T; Tanaka A; Noguchi A
    J Inherit Metab Dis; 2005; 28(2):187-202. PubMed ID: 15877208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucopolysaccharidosis IVA (Morquio A): identification of novel common mutations in the N-acetylgalactosamine-6-sulfate sulfatase (GALNS) gene in Italian patients.
    Tomatsu S; Filocamo M; Orii KO; Sly WS; Gutierrez MA; Nishioka T; Serrato OP; Di Natale P; Montaño AM; Yamaguchi S; Kondo N; Orii T; Noguchi A
    Hum Mutat; 2004 Aug; 24(2):187-8. PubMed ID: 15241807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Morquio A Clinical Assessment Program: baseline results illustrating progressive, multisystemic clinical impairments in Morquio A subjects.
    Harmatz P; Mengel KE; Giugliani R; Valayannopoulos V; Lin SP; Parini R; Guffon N; Burton BK; Hendriksz CJ; Mitchell J; Martins A; Jones S; Guelbert N; Vellodi A; Hollak C; Slasor P; Decker C
    Mol Genet Metab; 2013 May; 109(1):54-61. PubMed ID: 23452954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of liquid chromatography-tandem mass spectrometry and sandwich ELISA for determination of keratan sulfate in plasma and urine.
    Hintze JP; Tomatsu S; Fujii T; Montaño AM; Yamaguchi S; Suzuki Y; Fukushi M; Ishimaru T; Orii T
    Biomark Insights; 2011; 6():69-78. PubMed ID: 21792275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress and inflammation in mucopolysaccharidosis type IVA patients treated with enzyme replacement therapy.
    Donida B; Marchetti DP; Biancini GB; Deon M; Manini PR; da Rosa HT; Moura DJ; Saffi J; Bender F; Burin MG; Coitinho AS; Giugliani R; Vargas CR
    Biochim Biophys Acta; 2015 May; 1852(5):1012-9. PubMed ID: 25701642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a common mutation in mucopolysaccharidosis IVA: correlation among genotype, phenotype, and keratan sulfate.
    Tomatsu S; Dieter T; Schwartz IV; Sarmient P; Giugliani R; Barrera LA; Guelbert N; Kremer R; Repetto GM; Gutierrez MA; Nishioka T; Serrato OP; Montaño AM; Yamaguchi S; Noguchi A
    J Hum Genet; 2004; 49(9):490-494. PubMed ID: 15309681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of Elevated Concentrations of Urine Keratan Sulfate by UPLC-MSMS in Lysosomal Storage Disorders (LSDs): Comparison of Urine Keratan Sulfate Levels in MPS IVA Versus Other LSDs.
    Ellsworth KA; Pollard LM; Cathey S; Wood T
    JIMD Rep; 2017; 34():11-18. PubMed ID: 27469132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Di-sulfated Keratan Sulfate as a Novel Biomarker for Mucopolysaccharidosis II, IVA, and IVB.
    Shimada T; Tomatsu S; Mason RW; Yasuda E; Mackenzie WG; Hossain J; Shibata Y; Montaño AM; Kubaski F; Giugliani R; Yamaguchi S; Suzuki Y; Orii KE; Fukao T; Orii T
    JIMD Rep; 2015; 21():1-13. PubMed ID: 25712379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucopolysaccharidoses type I and IVA: clinical features and consanguinity in Tunisia.
    Khedhiri S; Chkioua L; Bouzidi H; Dandana A; Ben Turkia H; Miled A; Laradi S
    Pathol Biol (Paris); 2009 Jul; 57(5):392-7. PubMed ID: 18584975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation and polymorphism spectrum of the GALNS gene in mucopolysaccharidosis IVA (Morquio A).
    Tomatsu S; Montaño AM; Nishioka T; Gutierrez MA; Peña OM; Tranda Firescu GG; Lopez P; Yamaguchi S; Noguchi A; Orii T
    Hum Mutat; 2005 Dec; 26(6):500-12. PubMed ID: 16287098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model.
    Sawamoto K; Tomatsu S
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses.
    Kubaski F; Suzuki Y; Orii K; Giugliani R; Church HJ; Mason RW; Dũng VC; Ngoc CT; Yamaguchi S; Kobayashi H; Girisha KM; Fukao T; Orii T; Tomatsu S
    Mol Genet Metab; 2017 Mar; 120(3):247-254. PubMed ID: 28065440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.